NEW YORK (GenomeWeb News) – Spain's Institute of Molecular and Medical Genetics, or INGEMM, has purchased a CapitalBio Array Platform through the distributor Biotools, Biotools said today.

The Madrid-based INGEMM, located at the La Paz University Hospital, will also receive continuous training and advice from Biotools in the use of the platform and in the design of microarray experiments.

The company said the agreement is the beginning of "a close collaboration with INGEMM aimed at developing microarrays for pharmacogenomics and genetic disease diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.